Savara SVRA
NASDAQ SVRA
$5.08 +0.01 (+0.20%)
At close: Sep 29, 2026 · 4:00 PM EDT

Savara (SVRA) EBITDA Margin (2015 - 2020)

Updated

Savara's EBITDA Margin came in at -1294600.00% for Q4 2020, down 1290411.72 percentage points from the prior quarter.

Analysis

Savara (SVRA) EBITDA Margin (2015 - 2020) Analysis & Trends

For FY2020, Savara's EBITDA Margin was -19083.66%.

  • EBITDA Margin carries a five-year change of -8385.51 percentage points (FY2015 to FY2020).
  • Going back by year, EBITDA Margin was -2712.25% in FY2016 (+7985.90 pp).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 35.95%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 49.01%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 6.02%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 33.11%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 46.01%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -124.26%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 39.16%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 39.10%
10 Savara 1.04 Bn 1.04 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 -1,294,600.00%
Sep 30, 2020 -4,188.28%
Mar 31, 2017 -5,067.02%
Dec 31, 2016 -1,007.75%
Sep 30, 2016 -7,124.44%
Dec 31, 2015 -17,912.96%
API Access

Savara EBITDA Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda-margin&ticker=SVRA&period=max&api_key=YOUR_API_KEY